Issn Print: 2047-9956
Publication Date: 2017/03/01
CP-242 Bevacizumab in glioblastoma or anaplasic astrocytoma: effectiveness, safety and cost effectiveness analysis
MDP Vicente Sanchez; JM Cano Cano; R Perez Serrano; MT Franco Sereno; MDM Alañon Pardo; M Mallol Yañez; IDLD Benet Giménez; M Rodríguez Martínez
Author Information: Hospital Universitario General Ciudad Real, Pharmacy, Ciudad Real, Spain
|Checking for direct PDF access through Ovid|
This abstract was published in error and withdrawn at the author’s request.